WHO ICTRP trial
Prednisolone versus dexamethasone in chronic inflammatory demyelinating…
ISRCTN07779236 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN07779236 |
|---|---|
| Public title | Prednisolone versus dexamethasone in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) trial |
| Primary sponsor | Academic Medical Centre (AMC) (The Netherlands) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Netherlands |
| Conditions | Chronic inflammatory demyelinating polyradiculoneuropathy Nervous System Diseases Inflammatory polyneuropathy |
| Interventions | 1. Experimental treatment: After randomisation a patient will start with 6 cycles of dexamethasone 40 mg per day orally for 4 consecutive days, repeated every 28 days. The cycles start in week 1, 5, 9, 13, 17, and 21. Simultaneously… |
| Registration date | Jul 9, 2005 |
| Target size | 52 |
| Secondary IDs | MEC02/007 PREDICT |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: